n-(2,6-dimethylergoline-8-yl)-2,2-dimethylpropanamide has been researched along with sdz 208-912 in 7 studies
| Studies (n-(2,6-dimethylergoline-8-yl)-2,2-dimethylpropanamide) | Trials (n-(2,6-dimethylergoline-8-yl)-2,2-dimethylpropanamide) | Recent Studies (post-2010) (n-(2,6-dimethylergoline-8-yl)-2,2-dimethylpropanamide) | Studies (sdz 208-912) | Trials (sdz 208-912) | Recent Studies (post-2010) (sdz 208-912) |
|---|---|---|---|---|---|
| 14 | 0 | 0 | 12 | 1 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carlsson, A; Ekman, A; Hoffmann, WE; Lum, JT; Piercey, MF; Svensson, K | 1 |
| Clark, D; Ericsson, M; Furmidge, LJ; Johnson, D; Petry, N; Tong, ZY | 1 |
| Coward, DM; Dixon, AK; Enz, A; Karobath, M; Shearman, G; Urwyler, S; White, TG | 1 |
| Spealman, RD | 1 |
| Baldessarini, RJ; Huston-Lyons, D; Marsh, ER | 1 |
| Ackerman, JM; Clark, D; Johansen, PA; White, FJ | 1 |
| Gerlach, J; Peacock, L | 1 |
7 other study(ies) available for n-(2,6-dimethylergoline-8-yl)-2,2-dimethylpropanamide and sdz 208-912
| Article | Year |
|---|---|
Effects of the partial dopamine receptor agonists SDZ 208-911, SDZ 208-912 and terguride on central monoamine receptors. A behavioral, biochemical and electrophysiological study.
Topics: 4-Butyrolactone; Animals; Behavior, Animal; Brain; Dopamine; Dopamine Agents; Ergolines; Lisuride; Male; Motor Activity; Neurons; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Serotonin; Reserpine; Serotonin; Substantia Nigra; Time Factors | 1991 |
Behavioural profile of partial D2 dopamine receptor agonists. 1. Atypical inhibition of d-amphetamine-induced locomotor hyperactivity and stereotypy.
Topics: Animals; Dextroamphetamine; Dopamine Agents; Dose-Response Relationship, Drug; Ergolines; Lisuride; Motor Activity; Piperidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Stereotyped Behavior | 1991 |
Partial dopamine-agonistic and atypical neuroleptic properties of the amino-ergolines SDZ 208-911 and SDZ 208-912.
Topics: 4-Butyrolactone; Animals; Antipsychotic Agents; Apomorphine; Avoidance Learning; Behavior, Animal; Catalepsy; Dopamine; Dopamine Agents; Ergolines; Female; Male; Prolactin; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1990 |
Discriminative stimulus effects of cocaine in squirrel monkeys: lack of antagonism by the dopamine D2 partial agonists terguride, SDZ 208-911, and SDZ 208-912.
Topics: Animals; Cocaine; Discrimination, Psychological; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Lisuride; Male; Receptors, Dopamine D2; Saimiri | 1995 |
Effects of dopamine partial-agonist aminoergolines on dopamine metabolism in limbic and extrapyramidal regions of rat brain.
Topics: 4-Butyrolactone; Animals; Dihydroxyphenylalanine; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Ergolines; Extrapyramidal Tracts; Hydrazines; Limbic System; Male; Rats; Rats, Sprague-Dawley | 1994 |
Electrophysiological effects of putative autoreceptor-selective dopamine agonists on A10 dopamine neurons.
Topics: Animals; Azepines; Dopamine; Dopamine Agents; Electrophysiology; Ergolines; Indoles; Male; Neurons; Phenanthrenes; Rats; Rats, Sprague-Dawley | 1993 |
Effects of several partial dopamine D2 receptor agonists in Cebus apella monkeys previously treated with haloperidol.
Topics: Administration, Oral; Amphetamine; Animals; Antipsychotic Agents; Behavior, Animal; Benzothiazoles; Cebus; Disease Models, Animal; Dopamine Agents; Dopamine D2 Receptor Antagonists; Dyskinesia, Drug-Induced; Dystonia; Ergolines; Female; Haloperidol; Lisuride; Male; Piperidines; Pramipexole; Quinpirole; Raclopride; Salicylamides; Thiazoles | 1993 |